Surveys - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

How does your company apply QbD in sterile manufacturing?
We incorporate QbD principals during process design.:
22%
We use critical quality attributes during aseptic processing.:
33%
We use a QbD approach in quality risk management.:
26%
We use QbD in multiple stages.:
4%
We do not apply QbD.:
15%
Other Surveys
Raw materials supply chain security
What impact do mega-mergers of biopharmaceutical companies have on the development of new drugs?
Negative impacts on drug development
Pharmaceutical business challenges
Reason for seeking new position
Salary Satisfaction
Changing jobs
Job security
Regulatory Challenges
INTERPHEX 2013
Biosimilars
US Biotechnology Hubs
Regulatory Enforcement
Trade Shows
Patent Cliff
FDA confidentiality
Preventing counterfeiting
European Pharmacovigilance Activities
Generic Drug User Fees Amendments of 2012
European Legislation
Drug Settlements
Emerging Markets
Energy Efficiency
Energy Efficiency
Affordable Care Act
Drug Shortages
Transparency
Significant changes
Quality Management
Analytical equipment
DTC Advertising
Biologics Manufacturing
Powder properties
Sterile manufacturing
Social media
API Manufacturing
Lyophilization Advances
Injection technologies
Oral drug delivery
Generic-Drug User Fees
Innovation in Solid Dosage
Small-Molecule API Outsourcing
USP Monographs
Anticounterfeiting Solutions
FDA's Enforcement Strategy
Quality by Design and APIs
Outsourcing Biologics
FDA Biosimilars Pathway
High-potency APIs
Biosimilars
Emerging markets
Carbon footprints
Needleless devices
BioPharm Quick Poll
BioPharm Survey :: Involvement In the Biopharmaceutical Industry

ADVERTISEMENT

ADVERTISEMENT

Click here